CY1116356T1 - INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS - Google Patents

INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS

Info

Publication number
CY1116356T1
CY1116356T1 CY20151100490T CY151100490T CY1116356T1 CY 1116356 T1 CY1116356 T1 CY 1116356T1 CY 20151100490 T CY20151100490 T CY 20151100490T CY 151100490 T CY151100490 T CY 151100490T CY 1116356 T1 CY1116356 T1 CY 1116356T1
Authority
CY
Cyprus
Prior art keywords
organic products
infringement
oral organic
infringement resistance
resistance oral
Prior art date
Application number
CY20151100490T
Other languages
Greek (el)
Inventor
Benjamin Oshlack
Curtis Wright
David J Haddox
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP12167170.5A external-priority patent/EP2517710B1/en
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1116356T1 publication Critical patent/CY1116356T1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Κοινοποιείται σύνθεση οπιούχου ανταγωνιστή που περιλαμβάνει έναν οπιούχο ανταγωνιστή διασκορπισμένο σε μια μήτρα εξελασμένου τήγματος, όπου η μήτρα περιλαμβάνει ένα ή περισσότερα από ένα φαρμακευτικά αποδεκτό υδρόφοβο υλικό και καθιστά τον ανταγωνιστή ουσιαστικά μη αποδεσμευόμενο.An opioid antagonist composition comprising an opioid antagonist dispersed in a extruded melt matrix, wherein the matrix comprises one or more of a pharmaceutically acceptable hydrophobic material and renders the antagonist substantially non-releasing.

CY20151100490T 2000-02-08 2015-06-03 INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS CY1116356T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18136900A 2000-02-08 2000-02-08
EP12167170.5A EP2517710B1 (en) 2000-02-08 2001-02-08 Tamper-resistant oral opioid agonist formulations

Publications (1)

Publication Number Publication Date
CY1116356T1 true CY1116356T1 (en) 2017-02-08

Family

ID=58457932

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20151100446T CY1116294T1 (en) 2000-02-08 2015-05-18 INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS
CY20151100490T CY1116356T1 (en) 2000-02-08 2015-06-03 INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS
CY20151100491T CY1116357T1 (en) 2000-02-08 2015-06-03 INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20151100446T CY1116294T1 (en) 2000-02-08 2015-05-18 INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20151100491T CY1116357T1 (en) 2000-02-08 2015-06-03 INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS

Country Status (1)

Country Link
CY (3) CY1116294T1 (en)

Also Published As

Publication number Publication date
CY1116294T1 (en) 2017-02-08
CY1116357T1 (en) 2017-02-08

Similar Documents

Publication Publication Date Title
CY1114063T1 (en) INFRINGEMENT RESISTANCE ORAL ORGANIC PRODUCTS
CY2018009I1 (en) IMMUNOSPHERIN VARIATIONS AND THEIR USES
CY2016027I1 (en) POLYALKYLENE POLYMER COMPOUNDS AND USES THEREOF
CY1116924T1 (en) OPTIONAL INFRINGEMENT RESISTANCE PRODUCTS
PT1115372E (en) CONSUMABLE FILMS BY ORAL AND FAST DISSOLUTION
DE60306590D1 (en) Biodegradable polymer composition, filler therefor and molded article made therefrom
DE60110292D1 (en) Polymer and photoresist compositions
NO20053556D0 (en) Polymer conjugates of interferon-beta with enhanced biological potency.
DE60235579D1 (en) PHOTOCHROMIC POLYMER COMPOSITIONS AND ARTICLES THEREOF
CY2013032I1 (en) EXENDINE-4 CONJUGATE AND THEIR PHARMACEUTICAL USE
IS7735A (en) Benzodiazepine derivatives and pharmaceutical compositions containing them.
NO20031744D0 (en) New non-imadazole compounds and pharmaceutical compositions comprising such
DE60142197D1 (en) Pharmaceutical composition
DE60335426D1 (en) Pharmaceutical compositions containing an opioid antagonist
DE60302513D1 (en) Electroluminescent 9,9-bis (4-amino) -1,1'-biphenyl) fluorene derivatives
DE60111265D1 (en) PHARMACEUTICAL COMPOSITIONS WITH NMDA RECEPTOR AGONIST
DE60106556D1 (en) BLOCK POLYMER AND COMPOSITION THAT CONTAINS THIS
DE60113638D1 (en) ELECTRO-LUMINESCENT FILM AND THESE SWITCHES USED
NO20022645L (en) Pharmaceutical superdisintegrant
DE60143593D1 (en) Graft copolymer and thermoplastic resin composition
IT1318700B1 (en) MULTI-LAYER COMPOSITION INCLUDING FLUOROPOLYMERS AND POLYMERS HYDROGENATED.
ATE326968T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING TENATOPRAZOLE AND AN ANTI-INFLAMMATORY
DE60028670D1 (en) Ethylene-alpha-olefin copolymer and compositions thereof
ATE366128T1 (en) PHARMACEUTICAL COMPOSITION
DE60310526D1 (en) IVABRADINE-CONTAINING PHARMACEUTICAL COMPOSITION WITH ORAL DISPERSION